TG Therapeutics Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript
Great, I'll kick this off. Raymond James is pleased to have TG Therapeutics present at the 2021 Human Health and Innovation Conference. From the Company, we have Michael Weiss, Executive Chairman, President and Chief Executive Officer. And with that, I'll turn this over to you, Michael, for the presentation.
Okay. Thanks. I appreciate it. Thanks, everyone, for joining us. Let me just share my screen here, which hopefully shouldn't be too challenging. Okay, hopefully this is -- lets you slide in. Okay, all right. So again, thanks, Raymond James, for having us today. And I will be making some forward-looking statements. So, for those who are interested, I do encourage you to review our public disclosure documents available on the Internet.
So, okay, perfect. So, by the way, just a quick way of background, Company was founded in 2012 with the goal to develop novel treatment options for patients with B-cell diseases. Those
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |